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Copyright © 2009 JCBN Summary The urinary concentrations of 8-isoprostane and 8-hydroxy-2’-deoxyguanosine
(8-OHdG), which are biomarkers of oxidative stress, were measured in 677 Japanese people
without any diseases, and their correlations with lifestyle facotrs, lifestyle-related blood
biochemical parameters, and dietary intake of antioxidative vitamins were investigated. The
mean urinary concentration of 8-isoprostane and 8-OHdG was 0.58 ng/mg creatinine and
8.43 ng/mg creatinine, respectively. Mean urinary 8-isoprostane was significantly different in
terms of age, gender, smoking and alcohol consumption but not different in terms of body
mass index (BMI) and exercise. By multiple regression analysis, urinary 8-isoprostane was
significantly influenced by smoking and age. On the other hand, mean urinary 8-OHdG
showed differences only by age group. Multiple regression analysis revealed that urinary 8-
OHdG was significantly influenced by age, smoking, body weight, levels of high-sensitivity C-
reactive protein (Hs-CRP) and low density lipoprotein-cholesterol in females, although it was
significantly influenced by body weight in males. The present study shows that urinary 8-
isoprostane is associated with lipid peroxidation related-lifestyles such as smoking, and urinary
8-OHdG is associated with arteriosclerosis related-factors such as Hs-CRP. Our findings suggest
that 8-isoprostane and 8-OHdG appear to be prospective biomarkers for early prediction of
lifestyle related-disease risk at the population level.
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Introduction
As a result of oxygen metabolic processes, cells conti-
nuously produce free radicals and reactive oxygen species
(ROS) such as superoxide anion (O2−) and hydroxyl radicals
(OH￿) [1, 2]. These free radicals are generally neutralized
by the antioxidant defense system comprising enzymes
including catalase, superoxide dismutase, glutathione per-
oxidase and low-molecular-weight antioxidants such as β-
carotene and tocopherol [3]. Oxidative stress is defined as a
situation in which an increased level of ROS generation
overwhelms the antioxidative defense capacity, resulting in
oxidative damage to lipids, DNA and proteins [1]. Oxidative
stress is suspected to contribute to the initiation and progres-
sion of many diseases and even to the normal aging process.
Since ROS themselves are very reactive and have an
extremely short half-life, direct determination of them in
tissue or body fluids is generally impracticable [1], the
measurement of biomarkers of oxidatively modified cellular
constituents in biological samples as “intermediate endpoints
or early-outcome predictors” of disease development pro-N. Sakano et al.
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vides a promising strategy in public health field [4].
F2-isoprostanes, a group of bioactive prostaglandin F2-like
compounds generated by oxidatively catalyzed reaction of
arachidonic acid, are considered as the reliable marker of
lipid peroxidation in vivo [ 5]. The 8-isoprostane (8-iso-
prostaglandin F2α; the major F2-isoprostane), the well known
compound belonging to the F2-isoprostane class, is usually
quantified in urine instead of plasma for practical use
because of the short half life of plasma F2-isoprostane [5].
Elevated levels of plasma and/or urinary 8-isoprostane have
been reported in several conditions such as diabetes [6, 7],
alcoholic liver disease [8], and cardiovascular disease [9].
It is known that oxidative DNA damage occurs conti-
nuously in living cells. 8-Hydroxy-2'-deoxyguanosine (8-
OHdG), a product of oxidatively modified DNA base
guanine is the most representative product that may reflect
oxidative damage induced by ROS [1]. Urinary 8-OHdG
was reported in good association with diabetes mellitus [10],
chronic renal failure [11], and cancer [12].
These oxidative stress biomarkers were presumed to
change in the “pre-clinical stages of disease” among healthy
people because of the influence of unhealthy behavior
related to the lifestyles, such as smoking and alcohol
drinking. However, few studies engaged in assessment of
these oxidative stress biomarkers for a population who have
no disease [13]. Moreover, no data are available regarding
the gender differences in levels of 8-isoprostane and 8-
OHdG in people who have different lifestyle habits, but
have no disease at the time of health checkup.
The present study aimed to examine whether there is any
difference in the levels of biomarkers of oxidative stress
(8-isoprostane and 8-OHdG) among Japanese people who
have different lifestyle habits in order to find the usefulness
of these biomarkers as early predictors of disease risk at
population level.
Materials and Methods
Subjects
Data were obtained from a worksite lifestyle intervention
study in Japanese city offices in which 847 individuals were
participated. For the purpose of this study, we excluded
subjects who have any history of cancer, stroke, diabetes,
ischaemic heart disease or asthma, and who takes any kind
of medicines or supplements such as vitamins. A total of 680
subjects were selected, and then 3 persons were excluded
from data analysis because their urinary concentrations of
8-isoprostane and 8-OHdG were under the limit of detection
(LOD). Therefore, 677 subjects aged 20–67 years were
available for final data analysis. All subjects were instructed
to overnight fasting and not consume any beverage and
food except plain water before the measurement. The ethics
committee of Okayama University approved the study, and
all subjects gave informed consent.
Health assessment
Health assessment period was from September to
December, 2007. Blood samples were collected after over-
night fasting for at least 10 h. Serum and plasma were pre-
served at 4°C for the measurement of total cholesterol (TC),
triglycerides (TG), high density lipoprotein-cholesterol
(HDL-c), low density lipoprotein-cholesterol (LDL-c), and
high-sensitivity C-reactive protein (Hs-CRP). Their body
composition was evaluated by using the following respec-
tive parameters such as body weight, body mass index
(BMI). BMI was calculated by body weight (kg)/height (m)2
and BMI over 25 was diagnosed as obesity according to the
criteria for Japanese [14]. Information on lifestyles in-
cluding cigarette smoking, alcohol consumption, exercise,
and dietary habit was obtained by self-reported question-
naires. The amount of alcohol consumption was defined by
that one unit was considered to be equivalent to 9–12 g of
ethanol [15]. The alcohol intake habit was converted into the
number of units per week, and over 20 units of alcohol
consumption per week represented excessive drinking. Infor-
mation on dietary habit was obtained by a food frequency
questionnaire [16].
Analysis of oxidative stress biomarkers
Urinary 8-isoprostane and 8-OHdG were determined in
spot urine samples stored at −80°C before analysis, because
Helmersson and Basu reported that urinary F2-isoprostanes
isomers levels in spot urines showed no significant variation
from levels measured in 24-h urine samples in the same
healthy individuals by radioimmunoassay [17]. Møller and
Loft indicated that the correlation coefficient of 8-OHdG
measurements by enzyme-linked immunosorbent assay
(ELISA) between spot and 24-h urine sample was 0.87 [18].
Urinary 8-isoprostane was analyzed by commercially
available competitive enzyme immunoassay (EIA) kit
(Cayman Chemical Company, Ann Arbor, MI) [19–21], and
the intra-assay and inter-assay coefficients of variation (CV)
were 5.4% and 11.0%, respectively. Measurement of 8-
OHdG was carried out with an ELISA kit from the Japan
Institute for the Control of Aging, Fukuroi, Shizuoka, Japan
[22], and the intra-assay and inter-assay CV were 5.2% and
8.1%, respectively. Values for 8-isoprostane and 8-OHdG
were normalized by per milligram of creatinine measured in
urine (Creatinine test kit, R&D Systems, Minneapolis, MN).
Statistical analysis
Data are presented as mean ± standard error (S.E.) unless
stated elsewhere. Log-transformed data of urinary 8-
isoprostane, 8-OHdG, serum TG, Hs-CRP, dietary intake of
retinol and vitamin C were used in all analyses because of
their skewed distributions. Unpaired t-test was used to testOxidative Stress Biomarkers and Lifestyles
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gender differences in health assessment data and oxidative
stress biomarkers and to compare the concentrations of
oxidative stress biomarkers by gender in different age
groups. One-way analysis of variance (ANOVA) was used to
determined differences in concentrations of oxidative stress
biomarkers among groups of BMI, alcohol consumption,
and exercise. Pearson’s correlation analysis was performed
to examine the relation between oxidative stress biomarkers
and the variables. A stepwise multiple regression analysis
was performed to test the relationship between oxidative
stress biomarkers and the variables that have potential asso-
ciation with the biomarkers. A probability value of p<0.05
was considered to be statistically significant. All analyses
were performed using Statistical Package of SPSS 12.0 for
Windows.
Results
Subject characteristics
The characteristics of the subjects are presented in
Table 1. The proportion of male smokers was greater than
that of the females, and the proportion of excessive drinkers
(over the 20 units per week) in the males were greater than
that of the females. Health assessment data by gender are
shown in Table 2. The levels of TG, LDL-c, Hs-CRP in
males were significantly higher than those in females. The
males smoked more cigarettes a day and had longer smoking
period than the females. For dietary antioxidant vitamin
intakes, the females consumed more dietary retinol and
vitamin C daily than the males.
Oxidative stress biomarkers by age, gender, and lifestyles
The concentrations of oxidative stress biomarkers
according to the lifestyles are described in Table 3-1 and
Table 3-2. The concentration of urinary 8-isoprostane in
males was significantly higher than that in females
(p<0.001), and subjects under 40 years had higher levels of
urinary 8-isoprostane than those over 40 years. Smoking and
alcohol drinking were significantly positively associated
with urinary 8-isoprostane. Drinkers who consumed alcohol
over 20 units per week showed the highest level of 8-
isoprostane. However, BMI and exercise did not show any
significant relevance to urinary 8-isoprostane.
The concentration of urinary 8-OHdG had significant
relevance to age in both males and females. The subjects
over 40 years had higher concentration of 8-OHdG than
those under 40 years. In addition, BMI, smoking, alcohol
drinking and exercise did not show significant relevance to
urinary 8-OHdG.
Table 4 shows oxidative stress biomarkers by gender and
age groups. Between females and males, the concentrations
of urinary 8-isoprostane were significantly different in the
younger groups of 20–29 and 30–39 years, however, the
levels of urinary 8-OHdG were significantly different in the
older groups of 50–59 and 60–69 years. Interestingly, the
peak urinary 8-OHdG level in males was in the group of
Table 1. Characteristics of subjects
BMI indicates body mass index.
1 unit of alcohol = 9–12 g of ethanol
Variable
All Male Female
n (%) n (%) n (%)
Total 677 (100.0) 293 (100.0) 384 (100.0)
Age (year) <40 309 ( 45.6) 130 ( 44.4) 179 ( 46.6)
≥40 368 ( 54.4) 163 ( 55.6) 205 ( 53.4)
BMI (kg/m2) <18.5 67 ( 9.9) 14 ( 4.8) 53 ( 13.8)
18.5–24.9 477 ( 70.5) 205 ( 70.0) 272 ( 70.8)
≥25.0 133 ( 19.6) 74 ( 25.3) 59 ( 15.4)
Smoking Never 441 ( 65.1) 119 ( 40.6) 322 ( 83.9)
Smokers 236 ( 34.9) 174 ( 59.4) 62 ( 16.1)
Alcohol drinking 
(units/week)
No 222 ( 32.8) 62 ( 21.2) 160 ( 41.7)
<20 428 ( 63.2) 209 ( 71.3) 219 ( 57.0)
≥20 27 ( 4.0) 22 ( 7.5) 5 ( 1.3)
Exercise 
(times/week)
No 382 ( 56.4) 128 ( 43.7) 254 ( 66.1)
1–5 261 ( 38.6) 143 ( 48.8) 118 ( 30.7)
6 or over 34 ( 5.0) 22 ( 7.5) 12 ( 3.1)N. Sakano et al.
J. Clin. Biochem. Nutr.
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50–59 years, whereas that was in the group of 60–69 years in
females.
Relationship between oxidative stress biomarkers and health
examination variables
The results of Pearson’s correlation analysis between
oxidative stress biomarkers and health assessment data are
presented in Table 5-1 and Table 5-2. Urinary 8-isoprostane
in all subjects was significantly positively correlated with
body weight, smoking, and alcohol consumption, and
negatively correlated with age, dietary intake of retinol and
vitamin C. In males, urinary 8-isoprostane was significantly
negatively correlated with age and dietary intakes of β-
carotene, retinol and vitamin C, although in females there
were no significantly correlations with these parameters.
However, urinary 8-isoprostane in females was significantly
positively correlated with alcohol consumption.
Urinary 8-OHdG in all subjects was significantly positively
correlated with age, TC and LDL-c, and negatively corre-
lated with body weight and BMI. In both males and females,
significant correlations were shown between urinary 8-OHdG
and age or body weight. In females, there were significantly
positive correlations between urinary 8-OHdG and LDL-c,
Hs-CRP, and smoking. However, no significant correlation
between urinary 8-OHdG and dietary intakes of antioxidant
vitamins were observed.
As shown in Fig. 1 and Table 5-1, we did not find any
significant association between urinary 8-isoprostane and
8-OHdG (r = −0.066, p =0 . 0 8 6 ) .
Multiple regression analysis for oxidative stress biomarkers
The result of multiple regression analysis for urinary 8-
isoprostane is showed in Table 6-1. The model for males
demonstrated that age and smoking were important influential
factors of urinary 8-isoprostane (12.0%) after adjustment for
BMI, body weight, alcohol consumption, and dietary intakes
of vitamins. On the other hand, the model for females
revealed that smoking and age were important influential
factors of 8-isoprostane (2.4%). That is to say, the more
they smoked, the higher the concentrations of urinary 8-
isoprostane were. Moreover, the level of urinary 8-
isoprostane was decreased with aging in both males and
females.
The result of multiple regression analysis for urinary 8-
OHdG is described in Table 6-2. The model for males
indicated body weight was important influential factor of
urinary 8-OHdG (1.6%), and the model for females revealed
that age, body weight, smoking, Hs-CRP and LDL-c were
Table 2. Health parameters by gender
Each value represents the mean ± SE. (log-transformed data in TG, Hs-CRP, retinol and vitamin C)
**p<0.01 (by Unpaired t test)
BMI indicates body mass index;TC, total cholesterol; TG, triglycerides; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density
lipoprotein; CRP, C-reactive protein.
Individuals identified as under-reporting their dietary antioxidant vitamins intake were excluded from a food frequency questionnaire.
Variable
All 
(n = 677)
Male 
(n = 293)
Female 
(n = 384)
p value
Age (year) 41.4 ± 0.4 41.4 ± 0.6 41.4 ± 0.6 0.990
Weight (kg) 60.4 ± 0.5 68.5 ± 0.6 54.3 ± 0.5 <0.001**
BMI (kg/m2) 22.7 ± 0.1 23.6 ± 0.2 21.9 ± 0.2 <0.001**
TC (mg/dl) 203.0 ± 1.4 205.1 ± 2.0 201.3 ± 1.9 0.163
HDL-c (mg/dl) 63.4 ± 0.6 56.0 ± 0.7 69.0 ± 0.7 <0.001**
LDL-c (mg/dl) 124.2 ± 1.3 129.9 ± 1.9 119.9 ± 1.7 <0.001**
TG (mg/dl) 80.7 ± 0.01 100.3 ± 0.01 68.4 ± 0.01 <0.001**
High-sensitivity CRP (mg/dl) 0.03 ± 0.02 0.04 ± 0.03 0.02 ± 0.03 <0.001**
Life style
Cigarette number a day 6.36 ± 0.39 12.0 ± 0.7 2.1 ± 0.3 <0.001**
Smoking period (year) 6.73 ± 0.42 12.2 ± 0.7 2.5 ± 0.4 <0.001**
Smoking (No./day×year) 130.2 ± 9.4 255.1 ± 17.9 35.0 ± 5.8 <0.001**
Alcohol drinking (units/week) 3.74 ± 0.23 6.18 ± 0.43 1.88 ± 0.19 <0.001**
Dietary antioxidant vitamins
Tocopherol (mg/day) 6.98 ± 0.09 6.99 ± 0.15 6.97 ± 0.11 0.937
β-Carotene (μg/day) 2793.6 ± 65.4 2711.4 ± 98.8 2856.3 ± 87.2 0.273
Retinol (μg/day) 421.79 ± 0.01 391.56 ± 0.01 446.48 ± 0.01 0.001**
Vitamin C (mg/day) 58.14 ± 0.01 51.72 ± 0.02 63.58 ± 0.01 <0.001**Oxidative Stress Biomarkers and Lifestyles
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Table 3-1. Characteristics of subjects by urinary 8-isoprostane (ng/mg creatinine)
Variable
All (n = 677) Male (n = 293) Female (n = 384)
mean ± SE p mean ± SE p mean ± SE p
Total 0.58 ± 0.01 — 0.68 ± 0.02 — 0.52 ± 0.02 <0.001**$
Age (year)
<40 0.63 ± 0.02
0.044*
0.74 ± 0.03
0.101
0.56 ± 0.03
0.147
≥40 0.55 ± 0.02 0.64 ± 0.02 0.49 ± 0.03
BMI (kg/m2)
<18.5 0.56 ± 0.04
0.646
0.80 ± 0.09
0.712
0.51 ± 0.05
0.875 18.5–24.9 0.58 ± 0.02 0.68 ± 0.02 0.52 ± 0.02
≥25.0 0.62 ± 0.03 0.68 ± 0.03 0.55 ± 0.05
Smoking
Never 0.51 ± 0.02
<0.001**
0.55 ± 0.03
<0.001**
0.50 ± 0.02
0.032*
Smokers 0.75 ± 0.02 0.79 ± 0.02 0.64 ± 0.04
Alcohol drinking (units/week)
No 0.51 ± 0.03
0.004**
0.67 ± 0.03
0.958
0.46 ± 0.03
0.018* <20 0.62 ± 0.02 0.69 ± 0.02 0.56 ± 0.02
≥20 0.74 ± 0.09 0.69 ± 0.11 0.99 ± 0.04
Exercise (times/week)
No 0.57 ± 0.02
0.056
0.71 ± 0.03
0.343
0.50 ± 0.02
0.057 1-5 0.63 ± 0.02 0.68 ± 0.02 0.58 ± 0.03
6 or over 0.47 ± 0.08 0.56 ± 0.07 0.34 ± 0.19
Table 3-2. Characteristics of subjects by urinary 8-OHdG (ng/mg creatinine)
*p<0.05, **p<0.01 (gender, age, and smoking by Unpaired t test; BMI, alcohol drinking, and exercise by ANOVA)
$p value by Unpaired t test to test gender differences
Log-transformed data in urinary 8-isoprostane and 8-OHdG
Variable
All (n = 677) Male (n = 293) Female (n = 384)
mean ± SE p mean ± SE p mean ± SE p
Total 8.43 ± 0.01 — 8.18 ± 0.01 — 8.63 ± 0.01 0.086$
Age (year)
<40 7.91 ± 0.01
<0.001**
7.76 ± 0.01
0.021*
8.01 ± 0.01
0.003**
≥40 8.90 ± 0.01 8.53 ± 0.01 9.20 ± 0.01
BMI (kg/m2)
<18.5 8.63 ± 0.02
0.135
9.68 ± 0.05
0.107
8.37 ± 0.03
0.285 18.5–24.9 8.56 ± 0.01 8.21 ± 0.01 8.83 ± 0.01
≥25.0 7.90 ± 0.02 7.83 ± 0.02 7.98 ± 0.03
Smoking
Never 8.35 ± 0.01
0.377
7.98 ± 0.01
0.330
8.48 ± 0.01
0.109
Smokers 8.59 ± 0.01 8.31 ± 0.01 9.41 ± 0.02
Alcohol drinking (units/week)
No 8.49 ± 0.01
0.778
7.91 ± 0.02
0.448
8.73 ± 0.01
0.852 <20 8.43 ± 0.01 8.31 ± 0.01 8.54 ± 0.01
≥20 7.99 ± 0.03 7.72 ± 0.03 9.29 ± 0.09
Exercise (times/week)
No 8.59 ± 0.01
0.229
8.16 ± 0.01
0.912
8.82 ± 0.01
0.059 1-5 8.15 ± 0.01 8.23 ± 0.01 8.05 ± 0.02
6 or over 8.82 ± 0.03 7.96 ± 0.03 10.63 ± 0.04N. Sakano et al.
J. Clin. Biochem. Nutr.
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important influential factors of 8-OHdG, which explained
12.7% of the variation of urinary 8-OHdG. That is to say,
aging was the most influence factor for urinary 8-OHdG.
Leanness and smoking also had influence on urinary 8-
OHdG. Moreover, the more they smoked, the higher the
level of Hs-CRP, and the higher the concentrations of
urinary 8-OHdG were.
Discussion
The present study investigated the association of oxida-
tive stress biomarkers 8-isoprostane and 8-OHdG with
lifestyles in Japanese people. 8-Isoprostane and 8-OHdG
are markers of oxidative damage of DNA and membrane
lipid. There were few studies that evaluated the association
of these oxidative stress-related biomarkers with lifestyles or
lifestyle-related blood biochemical parameters in healthy
people.
The present results showed that mean urinary 8-isoprostane
levels in males were high in comparison with that in females
and there was a negative association between urinary 8-
isoprostane and age. Gender difference in urinary 8-
isoprostane was supported by several methods such as EIA
[23], radioimmunoassay [24], and gas chromatography-
mass spectrometry (GC/MS) [25]. The association of
urinary 8-isoprostane with age was not fully examined in the
published literatures. A few reports showed no agreement on
the association of urinary 8-isoprostane with age [26, 27].
It is unknown why urinary 8-isoprostane was higher among
people under 40 years, however, negative association of
urinary 8-isoprostane with age in our study was coincided
with the report by Frisard et al. [27].
Positive association of urinary 8-isoprostane with smoking
was demonstrated by many researchers [28–30]. In the long-
term smokers, oxidative stress and inflammation are involved
in the development of atherosclerosis and chronic obstruc-
tive pulmonary disease (COPD) [2]. ROS production in
circulating phagocytes, oxidized proteins, lipid peroxidation
products such as malonaldehyde and F2-isoprostane, and
reduced levels of antioxidants such as vitamin C, β-carotene
and glutathione were detected in serum of smokers [31]. Our
result that the level of urinary 8-isoprostane was negatively
correlated with dietary antioxidant vitamins might support
the possible consumption of antioxidant vitamins in serum
by smoking. Therefore, a significant increase in 8-isoprostane
in smokers and an association of 8-isoprotane with smoking
habits were not surprising results.
We did not observe gender difference in mean urinary 8-
OHdG levels, however, in the groups of 50–59 and 60–69
years, urinary 8-OHdG in females was significantly high
compared with those in males and in female group below 40
years. In published literatures, no consensus has been
reached on the association of urinary 8-OHdG with aging
[13, 32]. A lower urinary 8-OHdG level in women than in
men was reported by Loft et al. [ 33], whereas several
findings suggested that the level of urinary 8-OHdG in
females was higher than those in males [34]. In female
groups of 50–59 and 60–69 years of the present study,
high urinary 8-OHdG levels may be contributed by post-
menopausal state. Nakano et al. reported that at menopausal
age, urinary 8-OHdG was elevated by increased body iron
status [35]. In addition, during menopause, a decreased
production of oestrogen may also be involved in the eleva-
tion of urinary 8-OHdG. Much attention has been focused on
the antioxidant property of oestrogen related to the suppres-
sion of cholesterol synthesis in atherosclerotic patients [13].
Therefore, oestrogen levels and body iron status should be
kept in mind while discussing the gender difference in
urinary 8-OHdG.
In both sexes, urinary 8-OHdG was negatively associated
with body weight, which can be supported by reports that
showed an association of weight loss with 8-OHdG levels
regarding to a cancer risk of low BMI [36] and a negative
association of BMI with urinary 8-OHdG [37, 38]. However,
increased levels of urinary 8-OHdG in obese children was
observed [39]. Therefore, more studies are needed to fully
Table 4. Oxidative stress biomarkers according to gender and age groups
*p<0.05, **p<0.01
Each value represents the mean ± SE.
p values were analyzed by Unpaired t test between male and female.
Log-transformed data in urinary 8-isoprostane and 8-OHdG
Age groups (n) 8-isoprostane (ng/mg creatinine) 8-OHdG (ng/mg creatinine)
(years) All Male Female Male Female p Male Female p
20–29 (102) (43) (59) 0.78 ± 0.04 0.52 ± 0.05 0.011* 7.59 ± 0.02 7.97 ± 0.02 0.546
30–39 (207) (87) (120) 0.72 ± 0.03 0.57 ± 0.03 0.035* 7.85 ± 0.02 8.04 ± 0.02 0.667
40–49 (201) (97) (104) 0.66 ± 0.04 0.53 ± 0.03 0.056 8.19 ± 0.01 7.71 ± 0.02 0.316
50–59 (141) (56) (85) 0.61 ± 0.04 0.46 ± 0.04 0.055 9.35 ± 0.02 10.84 ± 0.02 0.027*
60–69 (26) (10) (16) 0.68 ± 0.05 0.39 ± 0.12 0.139 7.50 ± 0.05 12.20 ± 0.02 <0.001**Oxidative Stress Biomarkers and Lifestyles
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understand the relationship between 8-OHdG and body
weight in healthy people.
The relationship between smoking and urinary 8-OHdG is
complicated. Several reports showed that an association of
urinary 8-OHdG with smoking was related to oxidative
damage in lung tissue due to various chemicals in cigarette
smoke [33]. However, negative correlations between passive
smoking and urinary 8-OHdG have previously been reported
[40]. Although the reason for this discrepancy is unknown,
the grade of the cigarette filter or differences in the quality of
Table 5-1. Pearson’s correlation of urinary 8-isoprostane with each parameter
Variable
All (n = 677) Male (n = 293) Female (n = 384)
r p r p r p
Age (year) −0.098 0.011* −0.115 0.049* −0.090 0.079
Weight (kg) 0.130 0.001** 0.025 0.675 0.053 0.304
BMI (kg/m2) 0.068 0.076 −0.006 0.912 0.051 0.319
TC (mg/dl) −0.048 0.214 −0.090 0.126 0.030 0.559
HDL-c (mg/dl) −0.050 0.189 −0.033 0.575 0.063 0.219
LDL-c (mg/dl) −0.049 0.204 −0.088 0.134 −0.069 0.176
TG (mg/dl) 0.057 0.140 −0.030 0.603 0.022 0.662
Hs-CRP (mg/dl) 0.020 0.605 0.031 0.591 −0.040 0.436
urinary 8-OHdG (ng/mg Cre) −0.066 0.086 −0.099 0.090 −0.036 0.485
Life style
Smoking (No./day × year) 0.242 <0.001** 0.267 <0.001** 0.133 0.009**
Alcohol drinking (units/week) 0.121 0.002** 0.046 0.436 0.104 0.041*
Dietary antioxidant vitamins
Tocopherol (mg/day) −0.005 0.906 −0.056 0.341 0.032 0.529
β-Carotene (μg/day) −0.051 0.189 −0.149 0.011* 0.023 0.658
Retinol (μg/day) −0.100 0.010** −0.120 0.040* −0.056 0.275
Vitamin C (mg/day) −0.092 0.017* −0.124 0.034* −0.030 0.561
Table 5-2. Pearson’s correlation of urinary 8-OHdG with each parameter
*p<0.05, **p<0.01
Log-transformed data in 8-isoprostane, 8-OHdG, TG, Hs-CRP, retinol and vitamin C.
BMI indicates body mass index; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein; TG,
triglycerides; Hs-CRP, high-sensitivity C-reactive protein; Cre, creatinine.
Variable
All (n = 677) Male (n = 293) Female (n = 384)
r p r p r p
Age (year) 0.205 <0.001** 0.129 0.028* 0.248 <0.001**
Weight (kg) −0.142 <0.001** −0.139 0.017* −0.125 0.014*
BMI (kg/m2) −0.099 0.010** −0.126 0.031* −0.068 0.186
TC (mg/dl) 0.112 0.004** −0.044 0.452 0.076 0.136
HDL-c (mg/dl) 0.074 0.053 0.061 0.302 0.047 0.353
LDL-c (mg/dl) 0.105 0.006** −0.007 0.905 0.186 <0.001**
TG (mg/dl) −0.014 0.707 −0.075 0.201 0.068 0.186
Hs-CRP (mg/dl) 0.070 0.067 −0.031 0.595 0.140 0.006**
Life style
Smoking (No./day × year) 0.040 0.296 0.052 0.380 0.157 0.002**
Alcohol drinking (units/week) 0.007 0.849 −0.006 0.914 0.084 0.099
Dietary antioxidant vitamins
Tocopherol (mg/day) −0.057 0.136 −0.102 0.083 −0.031 0.551
β-Carotene (μg/day) −0.003 0.931 −0.074 0.205 0.032 0.528
Retinol (μg/day) −0.029 0.453 −0.084 0.152 −0.012 0.811
Vitamin C (mg/day) −0.021 0.593 −0.080 0.171 −0.005 0.921N. Sakano et al.
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cigarettes among countries might be a factor.
LDL-c has been known as a risk factor for atherosclerosis
[41], and Hs-CRP, which involves in inflammation, is also
accepted as a risk factor for cardiovascular events in
association with atherosclerosis [42], although it is not clear
whether plasma Hs-CRP reflects the arterial inflammation
because Hs-CRP is generated in the liver. Increased
immunoreactivity for 8-OHdG was observed in athero-
sclerosis plaque of the carotid artery wall [43] and common
intima-media thickness is a sign of atherosclerosis [44]. So
far, few studies have provided evidence that urinary 8-
OHdG increased in atherosclerotic patients. Our results that
showed a positive association of urinary 8-OHdG with
Hs-CRP and LDL-c may suggest a potential relationship
between urinary 8-OHdG and atherosclerosis. Moreover,
age, smoking, Hs-CRP, and LDL-c, indicated as influential
factors of urinary 8-OHdG by multiple regression analysis,
are known as coronary risk factors [41]. Therefore, urinary
8-OHdG may be a useful biomarker for early prediction of
atherosclerosis risk.
Our results did not show a significantly correlation
between urinary 8-isoprostane and 8-OHdG among all sub-
jects (n = 677). In the previous studies, some researchers
reported the elevated levels of 8-isoprostane and 8-OHdG
in the diabetics, although these studies have not shown the
association between 8-isoprostane and 8-OHdG [45, 46]. A
study by England et al. suggested there was no correlation
between any products of oxidative DNA damage including
8-hydroxyguanine and F2-isoprostanes levels among healthy
volunteers who were non-smokers (n = 53) [47]. Moreover,
Harman  et al. reported a significant correlation between
urinary 8-iso-prostaglandin F2α (IsopF2α) and urinary 8-
OHdG or 5-hydroxymethyl-2'-deoxyuridine (5-OHmU)
among 234 healthy subjects including 138 smokers, but they
did not observe such a correlation among never-smokers
[48]. Their results showed that 5-OHmU was more strongly
correlated with urinary IsopF2α than 8-OHdG. Whereas in
our study, in which the subjects included 35% smokers, there
was no correlation between urinary 8-isoprostane and 8-
OHdG, and there was also no correlation between these
2 markers among non-smokers (r = −0.069,  p = 0.146,
n = 441). Therefore, the relation between isoprostane and
8-OHdG might not be so strong. Further investigation is
needed to confirm these results.
Fig. 1. Pearson’s correlation between urinary 8-isoprostane and
8-OHdG in Japanese healthy people. No significant
correlations were found in both males (r = −0.099,
p = 0.090, n = 293), and females (r = −0.036, p = 0.485,
n = 384).
Table 6-1. Multiple regression analysis for urinary 8-isoprostane
Subjects
Explanatory 
variable
β p value
Adjusted 
R2
Malea) 0.120
Age −0.252 <0.001
Smoking 0.363 <0.001
Femaleb) 0.024
Smoking 0.146 0.004
Age −0.108 0.035
Table 6-2. Multiple regression analysis for urinary 8-OHdG
β indicates standardized partial regression coefficient.
Log-transformed data in 8-isoprostane, 8-OHdG, TG, Hs-CRP,
retinol and vitamin C.
Variables included in the model, for a): weight, BMI, TC, HDL-c,
LDL-c, TG, Hs-CRP, alcohol, exercise, tocopherol, β-carotene,
retinol, vitamin C; for b): weight, BMI, TC, HDL-c, LDL-c, TG,
Hs-CRP, alcohol, exercise, tocopherol, β-carotene, retinol, vitamin
C; for c): age, BMI, TC, HDL-c, LDL-c, TG, Hs-CRP, smoking,
alcohol, exercise, tocopherol, β-carotene, retinol, vitamin C; for
d): BMI, TC, HDL-c, TG, alcohol, exercise, tocopherol, β-
carotene, retinol, vitamin C.
BMI indicates body mass index; TC, total cholesterol; TG,
triglycerides; HDL-c, high-density lipoprotein cholesterol; LDL-c,
low-density lipoprotein; Hs-CRP, high-sensitivity C-reactive
protein.
Subjects
Explanatory 
variable
β p value
Adjusted 
R2
Malec) 0.016
Weight −0.139 0.017
Femaled) 0.127
Age 0.168 0.002
Weight −0.250 <0.001
Hs-CRP 0.209 <0.001
Smoking 0.102 0.036
LDL-c 0.109 0.050Oxidative Stress Biomarkers and Lifestyles
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As for the measurement of 8-isoprostane, several re-
searchers pointed out that mass spectrometric methods have
high sensitivity and specificity compared with immunoasays
[49]. However, at present, no more suitable methods instead
of immunoassays are available for the large scaled cross-
sectional study. Since many clinical researchers have
employed EIA Kit for the measurement of 8-isoprostane
[19–21], we used the most popular commercially available
competitive EIA kit of Cayman for the detection of urinary
8-isoprostane. The concentrations of urinary 8-isoprostane
by mass spectrometric methods in human controls were
reported in the range of 0.16–1.88 (ng/mg creatinine) [50–
52]. Therefore, our results, in which the mean urinary 8-
isoprostane was 0.58 (ng/mg creatinine), did not stray from
the values by mass spectrometric methods.
At present, there are two accepted methods for measuring
urinary 8-OHdG: high performance liquid chromatography
with electrochemical detection (HPLC-ECD) method [53]
and ELISA [22, 54]. Urinary 8-OHdG data by these two
methods showed a good correlation (r = 0.833; p<0.0001)
[55]. For unknown reasons, 10% of the urine samples
showed more than 4 times increase in 8-OHdG value by
ELISA in comparison with HPLC-ECD method. There are
two commercial kits for quantifying 8-OHdG using a
monoclonal antibody N45.1 from the Japan Institute for the
Control of Aging (Fukuroi, Shizuoka) and another mono-
clonal antibody (clone 1F7) from Trevigen (Gaithersburg,
MD). Chiou et al. found a good correlation between the
two kits with a correlation coefficient of 0.9 [12].
Although the present findings are significant, several
limitations of the study should be noted. First, causal rela-
tionships could not be determined because this study was a
cross-sectional study. Second, some reporting bias may have
been introduced because the information on lifestyle habits
like smoking, drinking, and dietary intakes was obtained
via self-reported questionnaires. Third, since there is no
validated method for measurement of isoprostane at popula-
tion level, present results should be interpreted with caution.
Further studies are needed to examine the analytical methods
of 8-isoprostane in comparison with the “gold standard”
mass spectrometric methods and to confirm the urinary level
of 8-isoprostane in healthy subjects with increased sample
size.
In conclusion, this study shows that urinary 8-isoprostane
is associated with lipid peroxidation related-lifestyles
such as smoking, and urinary 8-OHdG is associated with
arteriosclerosis related-factors such as higher levels of
Hs-CRP and LDL-c, body weight, and smoking. The present
findings suggest that 8-isoprostane and 8-OHdG appear to
be prospective biomarkers for early prediction of lifestyle
related-disease risk at the population level.
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